We are live on ! Find out more
PA

PharVision Advisers Portfolio holdings

AUM $9.86M
1-Year Est. Return 9.93%
This Fund
S&P 500
This Quarter Est. Return
+0.93%
1 Year Est. Return
+9.93%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$198M
AUM Growth
+$19.8M
Cap. Flow
+$23.3M
Cap. Flow %
11.78%
Top 10 Hldgs %
3.45%
Holding
1,063
New
409
Increased
141
Reduced
117
Closed
396

Top Buys

Rank Stock Value
1
DK icon
Delek US
DK
+$871K
2
AVGO icon
Broadcom
AVGO
+$691K
3
A icon
Agilent Technologies
A
+$650K
4
TLS icon
Telos
TLS
+$640K
5
PGY icon
Pagaya Technologies
PGY
+$627K

Top Sells

Rank Stock Value
1
ARRY icon
Array Technologies
ARRY
+$730K
2
VRT icon
Vertiv
VRT
+$639K
3
ZVRA icon
Zevra Therapeutics
ZVRA
+$635K
4
BOW
Bowhead Specialty Holdings
BOW
+$608K
5
RIGL icon
Rigel Pharmaceuticals
RIGL
+$581K

Sector Composition

Rank Sector Weight
1 Technology 18.19%
2 Industrials 15.13%
3 Financials 12.4%
4 Consumer Discretionary 11.79%
5 Healthcare 11.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ORRF icon
51
Orrstown Financial Services
ORRF
$836M
$474K 0.24%
13,385
+5,869
+78% +$205K
MDGL icon
52
Madrigal Pharmaceuticals
MDGL
$12.7B
$473K 0.24%
813
+231
+40% +$118K
SGHC icon
53
SGHC Ltd
SGHC
$7.45B
$473K 0.24%
39,598
+27,568
+229% +$331K
OI icon
54
O-I Glass
OI
$1.41B
$470K 0.24%
+31,871
New +$422K
FN icon
55
Fabrinet
FN
$16.9B
$466K 0.24%
+1,023
New +$445K
GFF icon
56
Griffon
GFF
$4.28B
$465K 0.24%
+6,307
New +$469K
LTM
57
LATAM Airlines Group S.A.
LTM
$15B
$464K 0.23%
+8,589
New +$407K
IMAX icon
58
IMAX
IMAX
$2.47B
$462K 0.23%
+12,510
New +$436K
ABBV icon
59
AbbVie
ABBV
$454B
$461K 0.23%
2,019
+947
+88% +$216K
CSTM icon
60
Constellium
CSTM
$4.02B
$461K 0.23%
24,466
-9,427
-28% -$156K
SONO icon
61
Sonos
SONO
$1.87B
$460K 0.23%
26,192
+5,663
+28% +$98.7K
COST icon
62
Costco
COST
$422B
$460K 0.23%
533
+137
+35% +$124K
PBR icon
63
Petrobras
PBR
$116B
$458K 0.23%
+38,680
New +$472K
ATRO icon
64
Astronics
ATRO
$3.47B
$456K 0.23%
+10,091
New +$423K
OGS icon
65
ONE Gas
OGS
$5.02B
$456K 0.23%
+5,901
New +$474K
ULCC icon
66
Frontier Group Holdings
ULCC
$1.4B
$455K 0.23%
+96,681
New +$428K
W icon
67
Wayfair
W
$12.5B
$454K 0.23%
4,524
-5,303
-54% -$510K
STX icon
68
Seagate
STX
$185B
$454K 0.23%
+1,648
New +$428K
TAC icon
69
TransAlta
TAC
$4.25B
$454K 0.23%
+35,899
New +$536K
TAP icon
70
Molson Coors Class B
TAP
$7.71B
$453K 0.23%
+9,699
New +$447K
DBI icon
71
Designer Brands
DBI
$298M
$446K 0.23%
60,091
+8,069
+16% +$38.8K
UWMC icon
72
UWM Holdings
UWMC
$624M
$446K 0.23%
+101,932
New +$548K
VVV icon
73
Valvoline
VVV
$5.05B
$446K 0.23%
+15,360
New +$493K
PAYS icon
74
Paysign
PAYS
$497M
$446K 0.23%
86,588
+34,607
+67% +$187K
VLTO icon
75
Veralto
VLTO
$23.2B
$445K 0.23%
+4,461
New +$451K
1 2
3
4 5

Similar funds

BS
BCI Securities Miami, Florida $10.1M AUM
RG
Raine Group New York $10.5M AUM 23.14% 1-Year Est. Return
MP
MVM Partners Boston, Massachusetts $10.8M AUM 61.97% 1-Year Est. Return
CCM
Crabel Capital Management Los Angeles, California $10.8M AUM 3.34% 1-Year Est. Return
DFA
Davies Financial Advisors Murrieta, California $10.9M AUM 21.57% 1-Year Est. Return
CCP
Caden Capital Partners Santa Monica, California $8.12M AUM 16.97% 1-Year Est. Return
FRT
FTX Recovery Trust League City, Texas $11.8M AUM
VH
Vitol Holding Rotterdam, Netherlands $11.9M AUM 27.28% 1-Year Est. Return

PharVision Advisers's Q4 2025 Portfolio in Review

As of Q4 2025, PharVision Advisers held 1,063 positions worth $198M, up 11% from $178M the previous quarter. Its ten largest holdings account for 3.5% of the portfolio.

PharVision Advisers deployed $23.3M of net new capital in Q4 2025, opening 409 new positions and adding to 141 existing holdings. Its largest new stake was Delek US: 24,407 shares worth $724K.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was Wayfair, an estimated $510K trimmed.

  • PharVision Advisers's largest Q4 2025 buy was Delek US: 24,407 shares worth $724K.
  • PharVision Advisers added most to NIO in Q4 2025, an estimated $557K increase.
  • PharVision Advisers's biggest Q4 2025 reduction was Wayfair, cutting an estimated $510K.
  • PharVision Advisers fully exited Array Technologies in Q4 2025, selling an estimated $730K.
  • PharVision Advisers's ten largest holdings make up 3.5% of its $198M portfolio in Q4 2025.
  • PharVision Advisers opened 409 new positions and closed 396 in Q4 2025.
  • PharVision Advisers's portfolio value rose 11% quarter-over-quarter to $198M.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.